Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schofield
G Ward

Showing results (891-900 of 904) with videos related to

Pageof 91
Sort By:
BJU International|May 12, 2019
Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratificationDouglas G Ward, Naheema S Gordon, Rebecca H Boucher, et al.
Alimentary Pharmacology & Therapeutics|September 27, 2020
Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposureEmma Flanagan, Peter R Gibson, Emily K Wright, et al.
Stem Cell Reports|May 10, 2023
Depletion of WFS1 compromises mitochondrial function in hiPSC-derived neuronal models of Wolfram syndromeMalgorzata Zatyka, Tatiana R Rosenstock, Congxin Sun, et al.
The American Journal of Gastroenterology|September 29, 2025
Gut Microbiota Are More Strongly Associated With Impairments in Health-Related Quality of Life Than Disease Activity in Inflammatory Bowel DiseaseRobert D Little, Thisun C Jayawardana, Fan Zhang, et al.
Alimentary Pharmacology & Therapeutics|October 14, 2017
Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseasesN Mitrev, N Vande Casteele, C H Seow, et al.
Zoological Studies|January 16, 2023
The Arthropod Associates of 155 North American Cynipid Oak GallsAnna K G Ward, Robert W Busbee, Rachel A Chen, et al.
BMJ Open|July 20, 2024
Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trialRobert D Little, Jo McKenzie, Ashish Srinivasan, et al.
Nature Microbiology|June 26, 2019
Evidence for phospholipid export from the bacterial inner membrane by the Mla ABC transport systemGareth W Hughes, Stephen C L Hall, Claire S Laxton, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|May 15, 2026
Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort StudyR Gilmore, T Pham, R G Fernandes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2025
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath TrialRichard T Bryan, Wenyu Liu, Sarah J Pirrie, et al.
Pageof 91

Showing results (891-900 of 904) with videos related to

Sort By:
Pageof 91
BJU International|May 12, 2019
Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratificationDouglas G Ward, Naheema S Gordon, Rebecca H Boucher, et al.
Alimentary Pharmacology & Therapeutics|September 27, 2020
Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposureEmma Flanagan, Peter R Gibson, Emily K Wright, et al.
Stem Cell Reports|May 10, 2023
Depletion of WFS1 compromises mitochondrial function in hiPSC-derived neuronal models of Wolfram syndromeMalgorzata Zatyka, Tatiana R Rosenstock, Congxin Sun, et al.
The American Journal of Gastroenterology|September 29, 2025
Gut Microbiota Are More Strongly Associated With Impairments in Health-Related Quality of Life Than Disease Activity in Inflammatory Bowel DiseaseRobert D Little, Thisun C Jayawardana, Fan Zhang, et al.
Alimentary Pharmacology & Therapeutics|October 14, 2017
Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseasesN Mitrev, N Vande Casteele, C H Seow, et al.
Zoological Studies|January 16, 2023
The Arthropod Associates of 155 North American Cynipid Oak GallsAnna K G Ward, Robert W Busbee, Rachel A Chen, et al.
BMJ Open|July 20, 2024
Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trialRobert D Little, Jo McKenzie, Ashish Srinivasan, et al.
Nature Microbiology|June 26, 2019
Evidence for phospholipid export from the bacterial inner membrane by the Mla ABC transport systemGareth W Hughes, Stephen C L Hall, Claire S Laxton, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|May 15, 2026
Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort StudyR Gilmore, T Pham, R G Fernandes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2025
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath TrialRichard T Bryan, Wenyu Liu, Sarah J Pirrie, et al.
Pageof 91